Bunge Global (NYSE: BG) insider transactions
In the twelve months to 10 November 2026, executives and directors of Bunge Global reported 3 open-market sales of 28,131 shares ($2.7m) and 2 open-market purchases of 6,500 shares ($689,050), by 3 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 September 2026 | Neppl John W | Chief Financial Officer | Grant or award | +253 | $119.25 | 149,448 | Form 4 |
| 1 September 2026 | Walt Markus | Director | Grant or award | +10 | $119.25 | 3,746 | Form 4 |
| 1 September 2026 | Garros Julio | Chief Operating Officer | Grant or award | +253 | $119.25 | 142,899 | Form 4 |
| 1 September 2026 | Jensen Anne | Director | Grant or award | +10 | $119.25 | 3,330 | Form 4 |
| 1 September 2026 | Mahoney Christopher | Director | Grant or award | +10 | $119.25 | 14,830 | Form 4 |
| 1 September 2026 | Simril Kenneth | Director | Grant or award | +10 | $119.25 | 9,824 | Form 4 |
| 1 September 2026 | Lustosa de Andrade Eliane Aleixo | Director | Grant or award | +10 | $119.25 | 7,292 | Form 4 |
| 1 September 2026 | Simmons Jerry Matthews JR | Controller, Principal Actg Off | Grant or award | +55 | $119.25 | 58,998 | Form 4 |
| 1 September 2026 | Winship Henry Ward Iv | Director | Grant or award | +10 | $119.25 | 34,483 | Form 4 |
| 1 September 2026 | Jojo Linda P | Director | Grant or award | +10 | $119.25 | 3,612 | Form 4 |
| 1 September 2026 | Browner Carol M. | Director | Grant or award | +10 | $119.25 | 30,625 | Form 4 |
| 1 September 2026 | Heckman Gregory A | Chief Executive Officer | Grant or award | +992 | $119.25 | 276,765 | Form 4 |
| 1 September 2026 | Podwika Joseph | Chief Legal Officer | Grant or award | +139 | $119.25 | 92,271 | Form 4 |
| 1 September 2026 | Zenuk Mark N | Director | Grant or award | +20 | $119.25 | 24,032 | Form 4 |
| 1 September 2026 | Sears Kellie | Chief Human Resources Officer | Grant or award | +117 | $119.25 | 31,874 | Form 4 |
| 1 September 2026 | McGurk Monica Houle | Director | Grant or award | +10 | $119.25 | 7,098 | Form 4 |
| 1 September 2026 | Dimopoulos Christos | EVP and CSO | Grant or award | +160 | $119.25 | 118,514 | Form 4 |
| 1 September 2026 | Isman Adrian | Director | Grant or award | +10 | $119.25 | 3,330 | Form 4 |
| 4 August 2026 | Mahoney Christopher | Director | Open-market purchase | +1,500 | $107.60 | 14,820 | Form 4 |
| 31 July 2026 | Mahoney Christopher | Director | Open-market purchase | +5,000 | $105.53 | 13,320 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Bunge Global page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.